LifeTech Scientific Corporation

Price Chart

Risk-Adjusted Performance

LifeTech Scientific Corporation (LFTSF) Price Performance

LifeTech Scientific Corporation (LFTSF) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at $0.23.

Over the past year, LFTSF has traded between a low of $0.23 and a high of $0.23.

LifeTech Scientific Corporation has a market capitalization of $1.03B.

About LifeTech Scientific Corporation

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. The company's products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, HeartR, and Konar-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; Futhrough endovascular needle systems; delivery systems, such as Fustar steerable and SteerEase introducers; Zoetrack guidewire; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; HearTone implantable cardiac pacing system; and SeQure snare systems, as well as pacemakers. It also involved in the biomedical research and development; properties leasing business; and developing, manufacturing, and trading of medical devices, as well as offers technical, consulting, and technology services. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, China.

Compare LifeTech Scientific Corporation

Side-by-side comparison against top Healthcare peers.